Sponsor
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
Posted
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Căutare
Categorii
- National
- International
- Business
- Technology
- Health
- Educaţie
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Citeste mai mult
Dr. Baburam’s secretariat hits back at Prachanda
KATHMANDU: Rekhi Gurung, personal aide to former Prime Minister and Nepal Samajwadi Party (Naya...
Dhanush to play former President Dr APJ Abdul Kalam in Om Raut’s biopic
MUMBAI: Actor Dhanush is all set to portray the Missile Man of India and the 11th President, Dr...
What is Amrit Bharat station scheme? PM Modi inaugurates 103 redeveloped railway stations - top facts for passengers
Prime Minister Narendra Modi is set to inaugurate the redeveloped Deshnoke railway station in...